The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Former NCI official’s nonprofit seeks to tell the stories of cancer patients
Patient Action for Cancer Research aims to show impact of federal research

Cancer Policy

Trump signs order to use AI to accelerate pediatric cancer research

White House announces “TrumpRx,” a new prescription drug website

Trump claims that autism is caused by Tylenol use during pregnancy, advises to “fight like hell not to take it”

Bhattacharya: New grant review criterion is “not political”

Ousted CDC director testifies before Senate HELP Committee

CDC’s ACIP makes changes to childhood vaccine recommendations in first meeting since Monarez’s ouster

Clinical Roundup

New therapy delays progression of recurrent prostate cancer, UCLA study shows

Utilization of proton therapy is increasing, but barriers to access remain, NAPT annual survey finds

American Lung Association launches campaign to address barriers to lung cancer screening and care

EU launches DISARM project to tackle ovarian cancer risk and early detection

Novel immune system boost helps fight cancer cells, JHU study finds

Genetic “Trojan horse” selectively kills cancer cells linked to Kaposi’s sarcoma, UC Davis study shows

In The Clinic
Conversation with The Cancer Letter

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account